City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS - and so many stories - that we've tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they're all connected.
July 12, 2017 | Samantha Bonar
Monica Curiel was 19 years old, a freshman in college, when diagnosed. Now a survivor, her book, Stella's Picture Day, for pediatric cancer patients, was published in May 2016.
June 29, 2017 | Katie Neith
Clinical trial results in positive outcomes for patients with relapsed or treatment-resistant disease. Hodgkin lymphoma is typically considered to be one of the most curable forms of cancer, but some with the disease relapse or find that their cancer is resistant to treatment. For patients like this, a fully human monoclonal antibody called avelumab has shown promising results in a phase 1 clinical trial for safety and efficacy.
June 5, 2017 | Michael Easterling
As an oncology nurse, Christine Magnus Moore, R.N., B.S.N., has cared for patients going through the most challenging circumstances one can imagine. But she didn’t fully comprehend the courage of these cancer patients until she became one herself.
May 26, 2017 | Samantha Bonar
Four years ago, Mark Paolera, now 39, was busy enjoying the typical active California lifestyle, including mountain biking, hiking and deep-sea fishing. After a battery of tests, Paolera was diagnosed with Stage 2 Hodgkin lymphoma in May of 2014.
January 9, 2017 | Abe Rosenberg
Everything changed when Hodgkin lymphoma patient Lowell Winer joined a Phase II clinical trial examining the effectiveness of brentuximab vedotin (BV) after a failed transplant. The BV worked immediately, achieving a complete remission which, year after year, proved to be durable beyond anyone's expectations.
December 17, 2016 | Letisia Marquez
For the 45th year in a row, City of Hope will participate in the Tournament of Roses Parade. This year, seven patients will welcome 2017 atop City of Hope’s Rose Parade float. Meet Hodgkin lymphoma survivor Commander Ann Clark.
December 5, 2016 | Denise Heady
For the 45th year in a row, City of Hope will participate in the Tournament of Roses Parade. This year, seven patients will welcome 2017 atop City of Hope’s Rose Parade float. Meet non-Hodgkin lymphoma survivor Darrell George.
August 16, 2016 | Letisia Marquez
Patients whose Hodgkin lymphoma has returned after a stem cell transplant have few treatment options available but a new drug tested at City of Hope may change that. ABC-7 in Los Angeles featured research by Robert Chen, M.D., on the use of the new medication – brentuximab vedotin (BV) – by these patients.
July 18, 2016 | City of Hope
Study, published in Blood, reports on five-year survival data, suggests targeted therapy should be standard of care for patients with relapsed or treatment-resistant Hodgkin lymphoma.